Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
about
Safety and efficacy of telbivudine for the treatment of chronic hepatitis BTwo-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions presentAntiviral therapy and resistance with hepatitis B virus infection.Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment.Treatment of chronic hepatitis B: focus on telbivudine.Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future.Safety evaluation of telbivudine.Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.Variations of pharmacokinetics of drugs in patients with cirrhosis.Cumulative incidence and risk factors of creatine kinase elevation associated with telbivudine.Telbivudine: a hepatitis B-specific antiviral.Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairment.Determination of telbivudine in the plasma of chronic hepatitis B patients in long-term treatment by high-performance liquid chromatographic-tandem mass spectrometry.
P2860
Q28972486-AAC86DC0-00B2-42A7-958B-A0D6CB735102Q33267067-DB07186F-9AAE-4604-B672-E3BC1DDB2C77Q33787531-2A187C00-D88F-4658-998E-5BF48D641672Q36313219-9CF3A7EE-862F-47DC-B190-2C8BA9075D8AQ37432074-A8A8C397-AEDE-4C56-B611-9366F92272E7Q37754603-47C9F3F0-042F-4104-A79A-D4FE2E1F2BDDQ37775959-580038F3-746F-4676-9B0E-0C305A99A71AQ38071400-EE287B41-9C3F-4A5C-9126-0F7BE6C8C937Q38676890-E6543835-D173-4711-B6C2-2265A4CB78C9Q40910330-D9651125-74F2-4CF6-AB3C-CB5442EAC29BQ45253502-FFAAC029-308D-4B81-B4B6-E2E77409B75FQ46036075-EFB53F87-CAE5-4E45-9F9A-6DB00DA6F3C5Q48283573-BA7D8E81-1089-412E-9A26-6B33899D3A55
P2860
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@ast
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@en
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@nl
type
label
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@ast
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@en
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@nl
prefLabel
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@ast
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@en
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@nl
P2093
P2860
P1476
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
@en
P2093
George C Chao
Gloria Dubuc Patrick
Harry W Alcorn
Nathaniel A Brown
Thomas C Marbury
William B Smith
Xiao-Jian Zhou
P2860
P304
P356
10.1128/AAC.50.5.1721-1726.2006
P407
P577
2006-05-01T00:00:00Z